Johnson & Johnson (JNJ) stock saw a decline, ending the day at $149.23 which represents a decrease of $-0.37 or -0.25% from the prior close of $149.6. The stock opened at $149.93 and touched a low of ...

This was the stock's second consecutive day of losses.

Johnson & Johnson (JNJ) closed the most recent trading day at $149.23, moving -0.25% from the previous trading session. This change was narrower than the S&P 500's daily loss of 0.3%. At the same time ...

Key Insights Given the large stake in the stock by institutions, Johnson & Johnson's stock price might be vulnerable ...

Wolfe Research has recently initiated Johnson & Johnson (JNJ) stock to Outperform rating, as announced on November 15, 2024, according to Finviz. Earlier, on July 23, 2024, Daiwa Securities had ...

Johnson & Johnson closed $19.62 below its 52-week high ($168.85), which the company achieved on September 4th.

Johnson & Johnson an even more interesting and timely stock to look at, is the fact that in trading on Friday, shares of JNJ ...

Given its better prospects, we believe that Bristol Myers Squibb stock (NYSE: BMY) is currently a better pharmaceutical pick over Johnson & Johnson stock (NYSE: JNJ). BMY stock trades at 8.3x its ...

Notably, the $205 average of analysts’ price estimate for ABBV, reflects over 20% upside from its current levels of around $165. While ABBV stock may outperform JNJ stock in the next three years ...

BMY stock has seen little change, moving slightly from levels of $55 in early January 2021 to around $60 now, vs. an increase of about 10% for JNJ from levels of $140 to $155 over this period.